semaglutide weight loss clinic champaign-urbana Medical in Champaign-Urbana, IL Semaglutide Weight Loss Injection In

SAN DIEGO, March 25, 2025 /PRNewswire/ FuturHealth, a leading provider of personalized weight-loss solutions, today announced the launch of Affirm (NASDAQ: AFRM), the payment network that empowers consumers and []

(Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that it is now offering Foundayo (orforglipron) to eligible patients through its weight management program

People with Type 2 diabetes taking semaglutide appeared to have a significantly lower risk of developing Alzheimer's compared to patients taking seven other diabetes drugs, researchers reported.

These effects were observed with central, but not peripheral, administration of the agonist and antagonist, suggesting receptor expression on the luminal, CSF-facing side of the choroid plexus, which aligned with GLP-1R-mediated modulation of luminally-expressed transporters in excised choroid plexus

Managing a routine that involves two pens whether you're rotating between an active and backup pen, using different pens for different compounds, or combining a GLP-1 pen with a hormone pen means carrying more supplies than a single-pen case can handle

Diabetes GLP-1s perform better but still leak demand: Diabetes-indicated GLP-1s show higher retention (24% at one year) and face fewer access hurdles due to broader coverage and disease framing, yet 76% of demand remains unmet